Prevalence of COPD Stable Overall From 2011 to 2021
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 16, 2023 -- From 2011 to 2021, there was no change in the prevalence of chronic obstructive pulmonary disease (COPD) overall, but increases were seen among adults aged ≥75 years, those in micropolitan counties, and among current or former smokers, according to research published in the Nov. 17 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Yong Liu, M.D., from the U.S. Centers for Disease Control and Prevention, and colleagues assessed trends and differences in self-reported physician-diagnosed COPD prevalence among U.S. adults using data from the 2011 to 2021 Behavioral Risk Factor Surveillance System.
The researchers observed no significant change in age-standardized prevalence of COPD from 2011 to 2021 (6.1 to 6.0 percent). For most states and subgroups, prevalence was stable; however, among adults aged 18 to 44 years, prevalence decreased significantly (average annual percentage change [AAPC], −2.0 percent), and it increased significantly among those aged ≥75 years, those living in micropolitan counties, and among current or former smokers (AAPCs, 1.3, 0.8, 1.5, and 1.2 percent, respectively). Among women, adults aged ≥65 years, those with a lower education level, those unable to work, those living in rural areas, and ever smokers, the prevalence of COPD remained elevated.
"Strategies can be tailored to address the prevention of COPD-related risk factors and the needs of adults disproportionately affected by COPD, including persons aged ≥75 years, those who ever smoked, and residents of rural areas," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Researchers Compare Race-Based, Race-Neutral Lung Function Equations
TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...
Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD
TUESDAY, May 21, 2024 -- For adults with undiagnosed asthma and chronic obstructive pulmonary disease (COPD), receipt of pulmonologist-directed treatment is associated with less...
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
TUESDAY, May 21, 2024 -- Dupilumab is associated with fewer exacerbations for patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.